Loopback Health in the INC 5000

Press Release

In collaboration with pharmacy leaders from our health system network, Loopback implemented a pharmacist-led disease education initiative across seven health systems to better recognize acute hepatic porphyria (AHP) symptoms in order to facilitate timely diagnosis and management.

We’re headed to the 2025 NASP Annual Meeting & Expo (Sept 14–17, Denver) to connect health systems and life sciences around one goal: advancing patient access and outcomes. We’ll share practical insights on data-driven HSSP growth and pharma IDN channel strategy.

Cambridge Health Alliance (CHA) is a vibrant, innovative health system, and Harvard Teaching Hospital, that strives to provide equity and excellence for everyone, every time. With over 140,000 patients in Boston’s metro-north region, CHA delivers outstanding patient care in convenient locations, ...

DALLAS, Sept. 25, 2024 /PRNewswire/ -- Loopback Analytics was selected for the Dallas Business Journal's Fast 50, an annual ranking of the fastest-growing middle market companies in North Texas.

Loopback is in the business of championing health system specialty pharmacy programs, and one of the ways we do this is by showcasing the good work our clients and industry partners are doing in the space. We’re starting a monthly client feature where we spotlight various health systems and share ...

DALLAS, July 24, 2024 /PRNewswire/ — Loopback Analytics, a leading provider of data analytics and market access services for health systems’ specialty pharmacy programs, is pleased to announce its collaboration with Loma Linda University Health, a comprehensive academic healthcare system, to ...

DALLAS, TX, US, February 7, 2024 /EINPresswire.com/ — Loopback Analytics is thrilled to announce that the Limited Distribution Drug (LDD) Access services of Acentrus Specialty, the nation’s largest specialty pharmacy network serving 142 health systems, has transitioned its clients and services to ...

In our last blog titled, ‘The Challenge with Breaking into the Specialty Pharmacy Network’, Jen Jagodzinski, PharmD, discussed the key stakeholders and payor market dynamics. Given these challenges, if you’re still interested in pursuing network relationships, how does one go about it? How does a ...